Multisensory 40-Hz Stimulation for Alzheimer's Disease
NCT: NCT07758751 · NOT_YET_RECRUITING
Brief Summary
This study aims to evaluate the safety and preliminary efficacy of combined auditory and visual 40-Hz stimulation in participants with biomarker-confirmed Alzheimer's disease spectrum disorders. A total of 60 participants with mild cognitive impairment due to Alzheimer's disease or mild Alzheimer's disease dementia will be randomly assigned in a 1:1 ratio to receive either active multisensory 40-Hz stimulation or sham stimulation. The intervention will be administered for 60 minutes once daily for 4 consecutive weeks. Clinical assessments, electroencephalography, multimodal magnetic resonance imaging, and blood biomarkers will be evaluated before and after the intervention. Additional clinical, electroencephalographic, and blood biomarker assessments will be performed at 3 and 6 months after the intervention.
Frequently Asked Questions
What is Multisensory 40-Hz Stimulation for Alzheimer's Disease?
Multisensory 40-Hz Stimulation for Alzheimer's Disease is a clinical trial registered under NCT07758751. Current status: NOT_YET_RECRUITING.
What is the status of NCT07758751?
The current status of NCT07758751 (Multisensory 40-Hz Stimulation for Alzheimer's Disease) is: NOT_YET_RECRUITING.
When did Multisensory 40-Hz Stimulation for Alzheimer's Disease start?
Multisensory 40-Hz Stimulation for Alzheimer's Disease started on 2026-09.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.